Quantifying eloquent locations for glioblastoma surgery using resection probability maps

Autor: Wim Bouwknegt, Georg Widhalm, Frederik Barkhof, Lorenzo Bello, Domenique M J Müller, Michiel Wagemakers, Shawn L. Hervey-Jumper, W. Peter Vandertop, Wimar A. van den Brink, Marnix G. Witte, Pierre A. Robe, Tommaso Sciortino, Seunggu J. Han, Barbara Kiesel, Marco Conti Nibali, Julia Furtner, Philip C. De Witt Hamer, Marco Rossi, Roelant S Eijgelaar, Hilko Ardon, Martin Visser, Jan C. de Munck, Alfred Kloet, Albert J S Idema, Mitchel S. Berger, Aeilko H. Zwinderman
Přispěvatelé: Neurosurgery, ANS - Neurovascular Disorders, ANS - Systems & Network Neuroscience, CCA - Cancer Treatment and Quality of Life, Epidemiology and Data Science, APH - Methodology, Radiology and nuclear medicine, Amsterdam Neuroscience - Brain Imaging, Amsterdam Neuroscience - Neuroinfection & -inflammation, CCA - Cancer Treatment and quality of life, Amsterdam Neuroscience - Neurovascular Disorders, Amsterdam Neuroscience - Systems & Network Neuroscience
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Male
Neoplasm
Residual

Biopsy
Kaplan-Meier Estimate
Logistic regression
Neurosurgical Procedures
0302 clinical medicine
glioma
Medicine
neurosurgery
BRAIN
Brain Mapping
medicine.diagnostic_test
Brain Neoplasms
General Medicine
Middle Aged
extent of resection
GLIOMAS
Treatment Outcome
030220 oncology & carcinogenesis
oncology
Female
NEWLY-DIAGNOSED GLIOBLASTOMA
Adult
medicine.medical_specialty
WHITE-MATTER TRACTS
residual volume
Extent of resection
Resection
MULTIFORME
03 medical and health sciences
Glioma
Humans
Karnofsky Performance Status
Grading (tumors)
Aged
Probability
Receiver operating characteristic
business.industry
EXTENT
medicine.disease
Survival Analysis
Surgery
ROC Curve
PREDICTS SURVIVAL
PATTERNS
reproducibility of results
Glioblastoma
business
030217 neurology & neurosurgery
RESPONSE ASSESSMENT
Zdroj: Journal of Neurosurgery, 134(4), 1091-1101. AMER ASSOC NEUROLOGICAL SURGEONS
Müller, D M J, Robe, P A, Ardon, H, Barkhof, F, Bello, L, Berger, M S, Bouwknegt, W, van den Brink, W A, Nibali, M C, Eijgelaar, R S, Furtner, J, Han, S J, Hervey-Jumper, S L, Idema, A J S, Kiesel, B, Kloet, A, de Munck, J C, Rossi, M, Sciortino, T, Peter Vandertop, W, Visser, M, Wagemakers, M, Widhalm, G, Witte, M G, Zwinderman, A H & de Witt Hamer, P C 2021, ' Quantifying eloquent locations for glioblastoma surgery using resection probability maps ', Journal of Neurosurgery, vol. 134, no. 4, pp. 1091-1101 . https://doi.org/10.3171/2020.1.JNS193049, https://doi.org/10.3171/2020.1.JNS193049
Journal of neurosurgery, 134(4), 1091-1101. American Association of Neurological Surgeons
Journal of Neurosurgery, 134(4), 1091-1101. American Association of Neurological Surgeons
ISSN: 1933-0693
0022-3085
DOI: 10.3171/2020.1.JNS193049
Popis: OBJECTIVE Decisions in glioblastoma surgery are often guided by presumed eloquence of the tumor location. The authors introduce the “expected residual tumor volume” (eRV) and the “expected resectability index” (eRI) based on previous decisions aggregated in resection probability maps. The diagnostic accuracy of eRV and eRI to predict biopsy decisions, resectability, functional outcome, and survival was determined. METHODS Consecutive patients with first-time glioblastoma surgery in 2012–2013 were included from 12 hospitals. The eRV was calculated from the preoperative MR images of each patient using a resection probability map, and the eRI was derived from the tumor volume. As reference, Sawaya’s tumor location eloquence grades (EGs) were classified. Resectability was measured as observed extent of resection (EOR) and residual volume, and functional outcome as change in Karnofsky Performance Scale score. Receiver operating characteristic curves and multivariable logistic regression were applied. RESULTS Of 915 patients, 674 (74%) underwent a resection with a median EOR of 97%, functional improvement in 71 (8%), functional decline in 78 (9%), and median survival of 12.8 months. The eRI and eRV identified biopsies and EORs of at least 80%, 90%, or 98% better than EG. The eRV and eRI predicted observed residual volumes under 10, 5, and 1 ml better than EG. The eRV, eRI, and EG had low diagnostic accuracy for functional outcome changes. Higher eRV and lower eRI were strongly associated with shorter survival, independent of known prognostic factors. CONCLUSIONS The eRV and eRI predict biopsy decisions, resectability, and survival better than eloquence grading and may be useful preoperative indices to support surgical decisions.
Databáze: OpenAIRE